Lamotrigine Tablet, Extended Release
Product Images NDC 13668-341

11 FDA label images from Torrent Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 13668-341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Structure)

1 (Structure)
Chemical structure of lamotrigine showing a substituted aromatic ring with two chlorine atoms and two sulfonamide groups attached.*
FDA Label Image

1 (Image Clinicalstudy1 Partialonsetseizure)

1 (Image Clinicalstudy1 Partialonsetseizure)
A responder rate chart displaying the improvement or worsening percentages of patients treated with Lamotrigine Extended-Release Tablets versus placebo. The graph plots responder rate on the vertical axis against the percent of patients on the horizontal axis for two groups: Lamotrigine Extended-Release Tablets (N=70) and placebo (N=73).*
FDA Label Image

2 (Image Clinicalstudy2 Partialonsetseizure)

2 (Image Clinicalstudy2 Partialonsetseizure)
A cumulative responder rate plot comparing Lamotrigine Extended-Release Tablets to placebo in patients. The x-axis shows percent of patients from 0 to 100, and the y-axis shows responder rate from -100% (worsening) to 100% (improvement). Two curves represent the outcomes for placebo and Lamotrigine, with Lamotrigine showing a higher responder rate overall.*
FDA Label Image

Image (Logo1)

FDA Label Image

Image (Tabletsappearence)

Image (Tabletsappearence)
A data table depicting Lamotrigine tablets with strengths 25 mg, 50 mg, 100 mg, and 200 mg. Each row shows tablet color from light yellow to yellow, light green to green, light orange to orange, and light blue to blue respectively, along with illustrations of the tablet's upper and lower faces displaying specific imprint codes.*
FDA Label Image

25 mg (Lamotriginr Er 25mg 30count Indrad)

25 mg (Lamotriginr Er 25mg 30count Indrad)
Lamotrigine Extended-Release Tablets, USP 25 mg, with 30 tablets per package. The label indicates the product is manufactured by Torrent Pharmaceuticals Limited and includes storage instructions and a caution note. The label also shows the NDC 13668-339-30 and states 'Rx only.' Two yellow film-coated tablets are depicted on the label.*
FDA Label Image

25 mg-dahej (Lamotrigineer 25mg 30count Dahej)

25 mg-dahej (Lamotrigineer 25mg 30count Dahej)
Lamotrigine 25 mg Extended-Release Tablets, USP, label for a 30-tablet bottle. The label shows dosage strength, extended-release formulation, NDC 13668-339-30, and manufacturer Torrent Pharmaceuticals Limited. It includes storage instructions and a caution to verify the product dispensed, emphasizing child-resistant packaging.*
FDA Label Image

50 mg (Lamotrigineer 50mg 30count Indrad)

50 mg (Lamotrigineer 50mg 30count Indrad)
Label for Lamotrigine Extended-Release Tablets, USP 50 mg by Torrent Pharmaceuticals Limited. The label indicates 30 tablets per container with directions to dispense with a medication guide. It includes cautionary storage instructions and dosage information, along with manufacturer details for Torrent Pharmaceuticals Ltd. and Torrent Pharma Inc. A barcode and NDC 13668-340-30 are visible.*
FDA Label Image

50 mg-dahej (Lamotrigineer 50mg 30count Dahej)

50 mg-dahej (Lamotrigineer 50mg 30count Dahej)
Lamotrigine Extended-Release Tablets USP 50 mg label for a 30-tablet bottle by Torrent Pharmaceuticals Limited. The label includes dosage strength, storage instructions, caution to verify product dispensed, and a note on dispensing the medication guide. The label also shows the NDC 13668-340-30 and a depiction of the 50 mg tablets.*
FDA Label Image

100 mg (Lamotrigineer 100mg 30count Indrad)

100 mg (Lamotrigineer 100mg 30count Indrad)
Lamotrigine Extended-Release Tablets, USP 100 mg carton label for 30 tablets by Torrent Pharmaceuticals Limited. The label includes storage instructions, dosage caution to see prescribing information, and a visual of two brown round tablets marked with identification codes. NDC 13668-341-30 is printed prominently along with a note to dispense the medication guide with the product.*
FDA Label Image

200 mg (Lamotrigineer 200mg 30count Indrad)

200 mg (Lamotrigineer 200mg 30count Indrad)
Packaging label for Lamotrigine Extended-Release Tablets, USP, 200 mg strength. The label indicates a 30-tablet count and highlights the once-a-day dosing. Manufactured by Torrent Pharmaceuticals Limited, the label includes cautionary storage instructions, dosage guidance reference, and an NDC barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.